Filing Details

Accession Number:
0001439222-19-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-15 16:05:09
Reporting Period:
2019-11-13
Accepted Time:
2019-11-15 16:05:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439222 Agios Pharmaceuticals Inc. AGIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405288 A Jacqualyn Fouse C/o Agios Pharmaceuticals, Inc.
88 Sidney Street
Cambridge MA 02139
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-13 40,322 $31.00 41,722 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. All shares were purchased at $31.00 per share in an underwritten public offering that closed on November 13, 2019.